In:
Brain, Oxford University Press (OUP), Vol. 142, No. 12 ( 2019-12-01), p. 3834-3851
Kurzfassung:
Dexamethasone is used to manage cerebral oedema in patients with glioblastoma, despite significant drawbacks. Herting et al. show that dexamethasone reduces oedema via inhibition of interleukin-1 signalling. They highlight a likely interaction between dexamethasone and immunotherapy, and propose that specific interleukin-1 inhibition may be preferable to dexamethasone for managing oedema.
Materialart:
Online-Ressource
ISSN:
0006-8950
,
1460-2156
DOI:
10.1093/brain/awz331
Sprache:
Englisch
Verlag:
Oxford University Press (OUP)
Publikationsdatum:
2019
ZDB Id:
1474117-9
SSG:
12